Leukemia Research Studies

< Back to Pediatric Cancer Research Studies Page

AML Relapse / Refractory

AAML1421: A Phase 1/2 Study of CPX-351 (NSC# 775341) Alone Followed by Fludarabine, Cytarabine, and G-CSF (FLAG) for Children With Relapsed Acute Myeloid Leukemia (AML)

  • Conditions: Leukemia AML Relapse, Adult - Leukemia AML Relapse

PURPOSE: This phase I/II trial studies the side effects and best dose of liposomal cytarabine-daunorubicin CPX-351 (CPX-351) when given with fludarabine phosphate, cytarabine, and filgrastim and to see how well they work in treating younger patients with acute myeloid leukemia that has come back aft ...More

AAML1522: A Phase II, Multicenter, single-arm, open label study to evaluate the activity, safety, and pharmacokinetics of Lenalidomide (REVLIMID®) in Pediatric subjections from 1 to 18 Years of age with Relapsed or Refractory Acute Myeloid Leukemia

  • Conditions: Leukemia AML Relapse

PURPOSE: To determine the activity of lenalidomide in the treatment of pediatric subjects with relapsed/refractory AML (with second or greater relapse or refractory to at least 2 prior induction attempts) measured by morphological complete response defined as either a CR or CRi within the fir ...More

ADVL1521: A Phase 2 Study of the MEK Inhibitor Trametinib in Children With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

  • Conditions: Leukemia AML Relapse, Adult - Leukemia AML Relapse

PURPOSE: This phase II trial studies how well trametinib works in treating patients with juvenile myelomonocytic leukemia that has come back or does not respond to treatment. Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
 DETAILED DESCRIP ...More

CPX-MA-1201: A Phase I/Pilot Study of CPX-351 for Children, Adolescents and Young Adults with Recurrent or Refractory Hematologic Malignancies.

  • Conditions: Lymphoma Hodgkin Relapse, Lymphoma Non Hodgkin Relapse, Leukemia ALL Relapse, Leukemia AML Relapse, Adult - Leukemia AML Relapse, Adult - Leukemia ALL Relapse, Adult - Lymphoma Non Hodgkin Relapse, Adult - Lymphoma Hodgkin Relapse

  PURPOSE: The purpose of this study is to test the safety of a study drug called CPX-351. This drug has been tested in adults but not yet in children and adolescents. This study tests different doses of the drug to see which dose is safer in children and adolescents. Patients who have blood ca ...More

M13-833: A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

  • Conditions: Leukemia ALL Relapse, Leukemia AML Relapse, Adult - Leukemia ALL Relapse, Adult - Leukemia AML Relapse, Lymphoma Non Hodgkin Relapse, Adult - Lymphoma Non Hodgkin Relapse, Sarcoma Osteosarcoma Relapse, Adult - Sarcoma Osteosarcoma Relapse, Adult - Sarcoma Ewing Relapse, Sarcoma Ewing Relapse, Sarcoma Rhabdomyosarcoma Relapse, Adult - Sarcoma Rhabdomyosarcoma Relapse, Neuroblastoma Relapse - Refractory, Adult - Neuroblastoma Relapse - Refractory, Liver Relapse - Refractory, Adult - Liver Relapse - Refractory, Kidney Relapse - Refractory, Adult - Kidney Relapse - Refractory, Solid Tumor Retinoblastoma Relapse - Refractory, Adult - Solid Tumor Retinoblastoma Relapse - Refractory, Solid Tumor Melanoma Relapse - Refractory, Adult - Solid Tumor Melanoma Relapse - Refractory, Solid Tumor Germ Cell Tumor Relapse - Refractory, Adult - Solid Tumor Germ Cell Tumor Relapse - Refractory, Solid Tumors - All Other, Solid Tumors - All Other, Adult - Solid Tumors - All Other

PURPOSE: An open-label, global, multi-center study to evaluate the safety and pharmacokinetics of venetoclax monotherapy, to determine the dose limiting toxicity (DLT) and the recommended Phase 2 dose (RPTD), and to assess the preliminary efficacy of venetoclax in pediatric and young adult participa ...More

T2016-003: Epigenetic Reprogramming in Relapse AML: A Phase 1 Study of Decitabine and Vorinostat Followed by Fludarabine, Cytarabine and G-CSF (FLAG) in Children and Young Adults with Relapsed/Refractory AML

  • Conditions: Leukemia AML Relapse, Adult - Leukemia AML Relapse

PURPOSE: This is a pilot study using decitabine and vorinostat before and during chemotherapy with fludarabine, cytarabine and G-CSF (FLAG). DETAILED DESCRIPTION: Decitabine is a demethylating agent and vorinostat is a HDAC inhibitor. The use of demethylating agents and HDAC inhibitors in combinatio ...More

Contact Us

Contact us.

To learn more about available leukemia clinical trials, contact us at cancer@cchmc.org or 513-636-2799.